PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Clomipramine Hydrochloride Capsules USP | 25mg |
 |
30 |
68180-0492-06 |
Anafranil® |
AB |
Tricyclic Antidepressant |
| Sevelamer Hydrochloride Tablets | 800mg |
|
180 |
70748-173-26 |
Renagel® |
AB |
Phosphate binders |
| Cyclosporine Ophthalmic Emulsion | 0.05% |
|
30 |
68180-214-60 |
Restasis® |
NA |
Calcineurin inhibitor immunosuppressants |
| Merzee® (norethindrone acetate and ethinyl estradiol and ferrous fumarate capsules) | 1 mg/20 mcg |
|
28 |
43386-371-32 |
Taytulla® |
AB |
Oral Contraceptives |
| Desoximetasone Cream USP | 0.05% |
 |
15g |
68180-949-04 |
Topicort® LP Emollient Cream (0.05%) Topicort® Cream (0.25%) |
AB |
Corticosteroid |
| Desoximetasone Ointment USP | 0.05% |
 |
15g |
68180-946-04 |
Topicort® Ointment |
AB |
Corticosteroid |
| Desvenlafaxine Extended-Release Tablets | 25mg |
|
30 |
68180-593-06 |
Pristiq® |
AB |
Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) |
| Doxycycline Monohydrate Capsules USP | 50mg |
|
50 |
68180-652-08 |
Monodox® |
AB |
Anti-Infectives |
| Clobetasol Propionate Cream USP | 0.05% |
 |
15g |
68180-0956-02 |
Temovate® |
AB1 |
Corticosteroid |
| Clobetasol Propionate Ointment | 0.05% |
 |
15g |
43386-0096-61 |
Temovate® |
AB |
Anti-inflammatory |
| Clobetasol Propionate Lotion | 0.05% |
|
59 mL |
68180-0536-02 |
Clobex® |
AB |
Anti-inflammatory |
| Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate for oral solution. | 1.6g per 6 ounces |
|
177mL |
43386-700-83 |
Suprep® Bowel Prep Kit |
AA |
Osmotic Laxative |
| Moxifloxacin Ophthalmic Solution USP | 0.5% |
 |
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
| Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
|
30 UD Vials |
70748-261-60 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
| Diclofenac Sodium Topical Solution | 2% |
|
112g |
68180-537-01 |
Pennsaid® 2% |
AB |
Topical nonsteroidal anti-inflammatory drug (NSAID) |
| Rufinamide Tablets USP | 200mg |
|
120 |
68180-804-16 |
Banzel® |
AB |
Anticonvulsants |
| Pentazocine and Naloxone Tablets USP | 50mg/0.5mg |
|
100 |
43386-680-01 |
Talwin® NX |
AB |
Adjunct to Anesthesia Opioid Analgesic |
| Lurasidone Hydrochloride Tablets | 20mg |
|
30 |
68180-671-06 |
Latuda® |
AB |
Atypical antipsychotics |
| Darunavir Tablets | 600mg |
|
30 |
68180-345-07 |
Prezista® |
AB |
Antiretrovirals |
| Turqoz™ | 0.3mg/0.03mg |
 |
28 x 3 |
68180-895-13 |
Lo/Ovral-28® |
AB |
Oral Contraceptives |
| Diazepam Rectal Gel | 10 mg & 20 mg |
|
4.4 cm & 6.0 cm |
43386-280-01 |
|||
| Bromfenac Ophthalmic Solution 0.07% | 0.07% |
 |
3mL |
68180-433-02 |
Prolensa® |
AT |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Varenicline Tartrate Tablets | 0.5mg-1.0mg |
|
53 |
70748-128-49 |
Chantix® |
AB |
Smoking Cessation Aids |
| Cyanocobalamin Nasal Spray | 500mcg/ spray |
|
4 UD |
43386-237-70 |
Nascobal® |
AB |
B12 Vitamins |
| Ganirelix Acetate Injection | 250mcg/0.5mL |
|
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
| Bromfenac Ophthalmic Solution 0.075% | 0.075% |
 |
5ml |
68180-434-01 |
Bromsite® |
AT |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Bromfenac Ophthalmic Solution 0.09% | 0.09% |
 |
1.7mL |
68180-436-01 |
Bromday® |
AT2 |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Doxycycline Capsules | 40mg |
|
30 |
70748-308-06 |
Oracea® |
AB |
Antibiotic |
| Mirabegron Extended-Release Tablets | 25mg |
|
30 |
68180-151-09 |
Myrbetriq® |
– |
Beta-3 Adrenergic Agonist |
| Doxycycline for Injection USP | 100mg/ vial |
 |
(10) single-dose vials |
70748-338-10 |
Vibramycin® |
AP |
Tetracycline Antibiotics |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
